News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

After Novartis AG (NVS) Scandal, Japan Considers Penalties for False Data


8/6/2013 6:59:17 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The government is considering new legislation to regulate clinical studies, in the wake of revelations of data falsification in clinical studies for a high blood pressure medicine. Prompted by recent allegations involving the drug Diovan, produced by Novartis Pharma K.K., the government is discussing establishing the new law to prevent recurrence of similar problems. It is expected to oblige researchers in clinical studies to preserve medical records and other data and submit them to the government.

Help employers find you! Check out all the jobs and post your resume.

Read at Pharmalot
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES